Tura Ferre
Bellaterra, CT 08193, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
AAV-mediated FGF21 gene therapy promotes health span extension by whole-body tissue-specific adaptations.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 11, 2025
Reversion of metabolic dysfunction-associated steatohepatitis by skeletal muscle-directed FGF21 gene therapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 01, 2024
AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity.
Journal: Molecular therapy. Methods & clinical development
Published: July 07, 2021
Vitamin D Receptor Overexpression in β-Cells Ameliorates Diabetes in Mice.
Journal: Diabetes
Published: August 02, 2019
FGF21 gene therapy as treatment for obesity and insulin resistance.
Journal: EMBO molecular medicine
Published: July 11, 2018
Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs.
Journal: Molecular therapy. Methods & clinical development
Published: March 22, 2017
ALOX5AP Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin Resistance.
Journal: Diabetes
Published: January 08, 2016
AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease.
Journal: Molecular therapy. Methods & clinical development
Published: January 01, 2014
Treatment of diabetes and long-term survival after insulin and glucokinase gene therapy.
Journal: Diabetes
Published: February 05, 2013
Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance.
Journal: Diabetes
Published: April 24, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026